In Depth 3 Mar 2023
Let’s Take a Closer Look at 7 Autoimmune Diseases Biotechs are Fighting to Treat
While we mostly think of disease as being caused by bacteria or viruses, an illness can often occur when the…
Eye Disease
- Latest Posts
News and Trends 7 Feb 2023
Endogena Therapeutics retinitis pigmentosa treatment gets FDA fast track designation
The US Food and Drug Administration (FDA) has designated the investigation of Endogena Therapeutics’ EA-2353 for the treatment of retinitis…
News and Trends 31 Jan 2023
Active Biotech trial confirms eye treatment safety
Active Biotech has announced the completion of the phase I clinical study testing the safety and tolerability of its newly-developed…
News and Trends 31 Jan 2023
Stargardt disease treatment gets FDA fast track
Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has announced that the U.S. Food…
ADVERTISEMENT
News and Trends 9 Dec 2022
Visiox Pharma announces FDA acceptance of glaucoma new drug application
Visiox Pharma, LLC has received notification from the U.S. Food and Drug Administration (FDA) that the agency has completed its…
News and Trends 1 Dec 2022
FDA clears SparingVision’s investigational new drug application to treat ocular diseases
SparingVision today announces that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND) for…
Interview 28 Nov 2022
Breaking barriers to gene therapies for childhood rare diseases
The majority of known rare genetic diseases affect children, and gene therapies could help them live normal lives. Miquel Vila-Perelló,…
More News! 10 Nov 2022
Eye disease therapies being developed after Breye Therapeutics’ €4M seed financing
Breye Therapeutics ApS a biopharmaceutical company developing therapies for retinal vascular diseases today (November 10) has closed a seed financing…
News and Trends 31 Oct 2022
Replay Bio launches HSV gene therapy company to target retinal eye disease
Replay Bio has announced the launch of Eudora, an HSV (herpes simplex virus) gene therapy company targeting genetic retinal diseases. …
News and Trends 24 Oct 2022
Syncona to acquire Applied Genetic Technologies Corporation
Healthcare company Syncona Limited says its newly established portfolio company has agreed to acquire, by a tender offer, all outstanding…
ADVERTISEMENT
News and Trends 27 Sep 2022
Protocol for treatment of neurotrophic keratopathy submitted to FDA by ReGenTree
Protocol for a second phase 3 clinical trial for a treatment for neurotrophic keratopathy (NK) - a degenerative disease of…
News and Trends 14 Sep 2022
SparingVision raises €75M for genomic medicines for ocular diseases
SparingVision, a genomic medicine company developing vision-saving treatments for ocular diseases, has raised €75 million ($75 million) in series B…
Best in Biotech 13 Sep 2022
The five hottest private biotech companies in India
India is brimming with biotech companies and a young and skilled workforce. Here’s a quick glance at the private healthcare…
News and Trends 9 Sep 2022
Improved vision with less eye injections for patients after primary endpoints met in trials
The primary endpoints in two clinical trials investigating drug aflibercept 8 mg with 12 and 16-week dosing regimes, for patients…
News and Trends 29 Aug 2022
Marketing authorization granted for treatment of serious retinal diseases
The European Commission has granted marketing authorization to Ranivisio, a treatment for several serious retinal diseases. Polpharma Biologics Group BV,…
News and Trends 8 Jul 2022
New drug application for treatment of dry eyes disease submitted to FDA
A treatment for dry eye symptoms associated with Meibomian gland dysfunction (MGD) has been submitted under a New Drug Application…
ADVERTISEMENT
News and Trends 23 Jun 2022
BRIM Biotechnology enters OTC trading in Taiwan
BRIM Biotechnology, Inc.has entered OTC (over the counter) trading in Taiwan. Established in July 2013, BRIM is a clinical-stage company…
News and Trends 15 Jun 2022
Sling Therapeutics emerges with $35M to tackle thyroid eye disease
Michigan-based biopharma company Sling Therapeutics, Inc. has launched, with $35 million in series A financing led by TPG's The Rise…
News and Trends 3 Mar 2022
Europe’s Ophthalmology Scene Stays Hot for Biotech Funding
Ophthalmology-focused startups had a record year for venture capital funding in 2021. Impressive Series A rounds and collaborations hint at…
In Depth 10 Mar 2021
Can Gene Therapy Cure Blindness?
Since the approval of the first gene therapy for blindness, there has been a wave of companies developing gene therapy…